Study: Skin enzyme testing could be key to Alzheimer's diagnosis

08/15/2006 | Reuters

The testing of certain enzymes in the skin of Alzheimer's patients could quickly and easily identify Alzheimer's disease, according to a new study. Researchers said the test would be the first to accurately diagnose the disease, which currently only can be confirmed with complex psychiatric assessments and examination of the brain after death.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Compliance Director
Abbott Laboratories
Santa Clara, CA
Junior to Mid-Level FDA Associate
Morgan Lewis
Washington, DC
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
Multiple Locations, SL_Multiple Locations
Senior Manager, Compliance
Fremont, CA